Clinical Efficacy and Safety of Efgartigimod in Autoimmune Encephalitis Patients

A retrospective cohort study of 15 autoimmune encephalitis patients treated with efgartigimod. The dataset includes modified Rankin Scale scores, Clinical Assessment Scale for Autoimmune Encephalitis scores, immunological parameters, and routine clinical laboratory data. It was authored by Jin Qin and published on figshare under a CC-BY-4.0 license.

Use Cases

• Assessing clinical improvement based on mRS and CASE score changes mentioned in the description
• Analyzing the correlation between serum IgG level reduction and patient outcomes
• Evaluating the safety profile of efgartigimod in a small, real-world cohort
• Comparing treatment response trends between different autoimmune encephalitis subtypes

Strengths

• Includes data from 15 patients, providing a preliminary cohort for analysis
• Reports statistically significant improvements in mRS and CASE scores (p < .001)
• Contains detailed immunological and clinical laboratory parameters

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• The study is a small retrospective cohort; findings require further validation

Provenance

Source

figshare

Collection Method

Retrospective analysis of patient records

Freshness

Last updated 2026-05-20 09:19:59